Omeros reported $333K in Cost of Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US $ 0.44M 0.6M
Adamas Pharmaceuticals ADMS:US 576K 49K
Adma Biologics ADMA:US $ 20.3M 1.46M
Aerie Pharmaceuticals AERI:US $ 7.9M 1.72M
Alexion Pharmaceuticals ALXN:US $ 125.4M 26.8M
Alnylam Pharmaceuticals ALNY:US $ 32.66M 2.41M
Biomarin Pharmaceutical BMRN:US $ 103.54M 23.52M
Dynavax Technologies DVAX:US $ 60.09M 45.24M
Gilead Sciences GILD:US $ 1223M 167M
Heron Therapeutics HRTX:US $ 11.35M 3.17M
Insmed INSM:US $ 10.18M 654K
Intercept Pharmaceuticals ICPT:US $ 0.66M 0.04M
Knight Therapeutics Inc GUD:CN C$ 35.57M 1.35M
MacroGenics MGNX:US 1.66M 1.64M
Omeros OMER:US $ 333K 9K
Pacira Pharmaceuticals PCRX:US $ 34.65M 0.6M
Pfizer PFE:US $ 9931M 2939M
Rockwell Medical RMTI:US $ 16.32M 0.92M
Sarepta Therapeutics SRPT:US $ 23.44M 3.93M
United Therapeutics UTHR:US $ 27.7M 9.5M
Vertex Pharmaceuticals VRTX:US $ 236.51M 8.54M